Showing results (311-320 of 422) with videos related to

Sort By:
Pageof 43
Current Pharmaceutical Design|January 28, 2020
Vilaprisan, a New Selective Progesterone Receptor Modulator in Uterine Fibroid Pharmacotherapy-Will it Really be a Breakthrough?Michal Ciebiera, Salvatore G Vitale, Simone Ferrero, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|April 14, 2025
Endometriosis-associated ovarian cancer: a different clinical entityUmberto Leone Roberti Maggiore, G Bogani, Biagio Paolini, et al.
Expert Opinion on Investigational Drugs|February 3, 2015
Investigational therapies currently in Phase II clinical trials for the treatment of pelvic serous carcinomasAlice Bergamini, Umberto Leone Roberti Maggiore, Simone Ferrero, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society|March 26, 2024
Endometriosis-associated ovarian cancer: a different clinical entityUmberto Leone Roberti Maggiore, G Bogani, Biagio Paolini, et al.
Journal of Gynecologic Oncology|May 11, 2019
Efficacy and fertility outcomes of levonorgestrel-releasing intra-uterine system treatment for patients with atypical complex hyperplasia or endometrial cancer: a retrospective studyUmberto Leone Roberti Maggiore, Fabio Martinelli, Giulia Dondi, et al.
Expert Opinion on Investigational Drugs|July 19, 2021
Linzagolix: a new GnRH-antagonist under investigation for the treatment of endometriosis and uterine myomasSusan Dababou, Simone Garzon, Antonio Simone Laganà, et al.
Critical Reviews in Oncology/Hematology|May 16, 2018
Role of bevacizumab in uterine leiomyosarcomaGiorgio Bogani, Antonino Ditto, Fabio Martinelli, et al.
Hemasphere|May 26, 2023
Unmet Clinical Needs in the Management of Idiopathic Multicentric Castleman Disease: A Consensus-based Position Paper From an ad hoc Expert PanelPier Luigi Zinzani, Marco Paulli, Luca Arcaini, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 26, 2022
"Better late than never but never late is better", especially in young women. A multicenter Italian study on diagnostic delay for symptomatic endometriosisIda Pino, Gaia Maria Belloni, Valeria Barbera, et al.
Expert Opinion on Investigational Drugs|November 1, 2016
Folate receptor alpha antagonists in preclinical and early stage clinical development for the treatment of epithelial ovarian cancerAlice Bergamini, Simone Ferrero, Umberto Leone Roberti Maggiore, et al.
Pageof 43